Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraceptive vaccines.

Eileen A McLaughlin1, Michael K Holland, R John Aitken

  • 1ARC Centre of Excellence in Biotechnology & Development, Discipline of Biological Sciences, University of Newcastle, Callaghan NSW2308, Australia.

Expert Opinion on Biological Therapy
|July 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of Different Sperm Isolation Strategies for Fresh and Cryopreserved Human Spermatozoa Using a Simple Method for Simultaneously Assessing Sperm Vitality and DNA Fragmentation.

Andrology·2026
Same author

Declining global fertility and our future dependence on ART.

Reproductive biomedicine online·2026
Same author

Analysis of antioxidant activity in commercial IVF media.

Reproductive biomedicine online·2026
Same author

Mining public mass spectrometry data to map the bull sperm membrane-associated proteome.

Reproduction & fertility·2026
Same author

Semen analysis as a biomarker of male aging: biological mechanisms, clinical implications, and public health perspectives.

Human reproduction (Oxford, England)·2025
Same author

The nuclear transport factor IPO5 revealed as a critical mediator of male germline development†.

Biology of reproduction·2025

Developing a long-acting contraceptive vaccine requires identifying safe targets. Current research explores zona pellucida, sperm antigens, and anti-human chorionic gonadotropin (hCG) vaccines, each with challenges and potential. Future work focuses on novel targets and improved vaccine technologies.

Area of Science:

  • Reproductive immunology
  • Vaccine development
  • Human fertility control

Background:

  • Contraceptive vaccines offer a revolutionary approach to fertility control.
  • Research has focused on three main targets: zona pellucida (ZP), sperm surface antigens, and human chorionic gonadotropin (hCG).

Purpose of the Study:

  • To review the progress and challenges in developing effective contraceptive vaccines.
  • To evaluate the potential and limitations of different target strategies for vaccine development.

Main Methods:

  • Review of existing research on zona pellucida, sperm surface antigens, and anti-hCG vaccines.
  • Analysis of clinical trial data and immunological responses.

Main Results:

Related Experiment Videos

  • Zona pellucida (ZP) vaccines show promise but are hampered by ovarian pathology and difficulty maintaining antibody titers.
  • Sperm surface antigen vaccines have yet to identify a molecule that fulfills efficacy promises.
  • Anti-hCG vaccines have reached clinical trials and appear safe and potentially effective, though antibody generation variability poses a reliability concern.

    • Conclusions:

    • Contraceptive vaccine development necessitates continued exploration for suitable targets.
    • Advancements in vaccine technology are crucial for improving immunisation procedures and overcoming current limitations.
    • Addressing challenges like ovarian pathology and inter-individual variability is key for future success.